cnn.com
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial | CNN
Moderna’s mRNA vaccine combined with Merck’s immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the companies said on Wednesday, sending shares of the vaccine maker up 60% in prem...